Thomas K. Equels is CEO & President at AIM ImmunoTech Inc. (AIM). They have made 25 open-market trades across 1 company since 2023, most recently 2026-09-17.
25 open-market purchases totalling $403K since 2023, never a sale. Across 21 scored buys the stock is up 957.9% at ninety days, and 952.7 points ahead of the S&P over the same stretch.
25 scored purchases · one row per filing · discretionary only
| Ticker | Shares | Value |
|---|---|---|
| AIM | 126,822 | $22K |
Shares reported on the most recent Form 4, priced at the 2026-09-18 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 28% | 32% | 29% |
| Avg Move | +398.9% | +427.4% | +957.9% |
| Alpha | +397.8% | +427.0% | +952.7% |
| Scored | 25 | 22 | 21 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| AIM | BUY | 2026-09-17 | 2026-09-18 | $0.21 | $5K | -13.8% | — | — |
| AIM | BUY | 2026-09-16 | 2026-09-17 | $0.21 | $2K | -18.5% | — | — |
| AIM | BUY | 2026-09-15 | 2026-09-16 | $0.22 | $5K | -13.1% | — | — |
| AIM | BUY | 2026-09-14 | 2026-09-15 | $0.22 | $1K | -11.0% | -19.0% | — |
| AIM | BUY | 2025-06-13 | 2025-06-16 | $7.70 | $824 | +4.7% | +4.1% | -70.0% |
| AIM | BUY | 2025-06-12 | 2025-06-13 | $8.70 | $896 | +9988.2% | +9541.7% | +2639.7% |
| AIM | BUY | 2025-04-11 | 2025-04-23 | $0.03 | $118K | +0.0% | +0.0% | +8751.5% |
| AIM | BUY | 2025-04-04 | 2025-04-07 | $0.06 | $2K | +0.0% | +0.0% | +9225.6% |
| AIM | BUY | 2025-03-05 | 2025-03-06 | $0.13 | $7K | -9.2% | -27.0% | -27.0% |
| AIM | BUY | 2025-03-04 | 2025-03-05 | $0.12 | $5K | -12.4% | -30.7% | -30.7% |
| AIM | BUY | 2025-03-04 | 2025-03-04 | $0.12 | $10K | -6.1% | -4.8% | -23.2% |
| AIM | BUY | 2024-12-18 | 2024-12-19 | $0.21 | $5K | +14.7% | +15.9% | -35.1% |
| AIM | BUY | 2024-11-21 | 2025-01-21 | $0.21 | $4K | -12.6% | -38.2% | -58.9% |
| AIM | BUY | 2024-11-20 | 2024-11-21 | $0.20 | $17K | -2.2% | -11.4% | -36.8% |
| AIM | BUY | 2024-11-20 | 2024-11-20 | $0.18 | $11K | +3.0% | -5.0% | -31.5% |
| AIM | BUY | 2024-09-16 | 2024-09-17 | $0.30 | $2K | -9.3% | -16.1% | -32.0% |
| AIM | BUY | 2024-09-13 | 2024-09-16 | $0.31 | $6K | -16.9% | -20.0% | -35.4% |
| AIM | BUY | 2024-05-06 | 2024-05-07 | $0.41 | $25K | -6.3% | +3.7% | -25.0% |
| AIM | BUY | 2024-03-15 | 2024-03-18 | $0.33 | $25K | +15.2% | +16.3% | +3.9% |
| AIM | BUY | 2023-11-27 | 2023-11-27 | $0.44 | $15K | +25.2% | +10.1% | -8.5% |
| AIM | BUY | 2023-09-29 | 2023-09-29 | $0.44 | $10K | -0.1% | -1.3% | +3.4% |
| AIM | BUY | 2023-08-25 | 2023-08-25 | $0.67 | $6K | -6.1% | -20.5% | -33.3% |
| AIM | BUY | 2023-08-24 | 2023-08-24 | $0.67 | $10K | -10.6% | -23.6% | -36.6% |
| AIM | BUY | 2023-07-17 | 2023-07-17 | $0.59 | $10K | -8.5% | -1.3% | -27.0% |
| AIM | BUY | 2023-01-03 | 2023-01-04 | $0.31 | $100K | +79.1% | +30.7% | +3.6% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.